Fifth Third Bancorp
VIR icon

Fifth Third Bancorp’s Vir Biotechnology VIR Stock Holding History

Fifth Third Bancorp’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
26,395
+71
+0.3% +$675 ﹤0.01% 2447
2026
Q1 		$236K Buy
26,324
+24,471
+1,321% +$195K ﹤0.01% 2452
2025
Q4 		$11.2K Hold
1,853
– – ﹤0.01% 2092
2025
Q3 		$10.6K Buy
1,853
+1,202
+185% +$6.15K ﹤0.01% 2126
2025
Q2 		$3.28K Sell
651
-848
-57% -$4.55K ﹤0.01% 2285
2025
Q1 		$9.71K Buy
1,499
+239
+19% +$2.13K ﹤0.01% 2012
2024
Q4 		$9.25K Sell
1,260
-665
-35% -$5.25K ﹤0.01% 1999
2024
Q3 		$14.4K Buy
1,925
+890
+86% +$7.73K ﹤0.01% 1881
2024
Q2 		$9.21K Sell
1,035
-2,191
-68% -$21K ﹤0.01% 1954
2024
Q1 		$32.7K Buy
3,226
+676
+27% +$6.88K ﹤0.01% 1518
2023
Q4 		$25.7K Sell
2,550
-1,391
-35% -$12.7K ﹤0.01% 1678
2023
Q3 		$36.9K Buy
3,941
+1,613
+69% +$23K ﹤0.01% 1475
2023
Q2 		$57.1K Buy
2,328
+159
+7% +$3.99K ﹤0.01% 1314
2023
Q1 		$50.5K Buy
2,169
+1,070
+97% +$27.4K ﹤0.01% 1430
2022
Q4 		$27.8K Sell
1,099
-18
-2% -$441 ﹤0.01% 1584
2022
Q3 		$22K Buy
1,117
+9
+0.8% +$229 ﹤0.01% 1658
2022
Q2 		$28K Buy
1,108
+108
+11% +$2.52K ﹤0.01% 1603
2022
Q1 		$26K Buy
1,000
+375
+60% +$11.1K ﹤0.01% 1719
2021
Q4 		$26K Hold
625
– – ﹤0.01% 1768
2021
Q3 		$27K Hold
625
– – ﹤0.01% 1681
2021
Q2 		$30K Hold
625
– – ﹤0.01% 1654
2021
Q1 		$32K Sell
625
-625
-50% -$33.7K ﹤0.01% 1601
2020
Q4 		$33K Hold
1,250
– – ﹤0.01% 1532
2020
Q3 		$43K Buy
1,250
+500
+67% +$21.5K ﹤0.01% 1379
2020
Q2 		$31K Buy
+750
New +$25.2K ﹤0.01% 1446

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fifth Third Bancorp's VIR Position: Q2 2026 in Review

Fifth Third Bancorp increased its Vir Biotechnology (VIR) stake by 0.27% in Q2 2026, buying an estimated $675 and bringing the position to 26,395 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Fifth Third Bancorp first reported a position in VIR in Q2 2020 and has held it in 25 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Fifth Third Bancorp held 26,395 shares of Vir Biotechnology worth $269K as of Q2 2026.
  • Fifth Third Bancorp bought 71 Vir Biotechnology shares in Q2 2026, an estimated $675.
  • Vir Biotechnology made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2447 holding.
  • Fifth Third Bancorp first reported a position in Vir Biotechnology in Q2 2020 and has held it in 25 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.